Breast Neoplasms: all 12,820 studies
Page 79 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Parallel Comparison of 18 Gene Classifiers and Oncotype DX (Nanostring)CompletedNCT03772197
- Loreline Study: Characterization of Long Responders Under EribulineCompletedNCT03771183
- Team Based Psychosocial Care to Promote, Maintain and Restore Wellness of Breast Cancer PatientsCompletedNCT03770598Not applicable
- Postoperative Analgesia in Breast Cancer Surgery: Safety and Efficiency of Ultrasound Guided Erector Spinae Plane BlockCompletedNCT03769428Not applicable
- Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergoing Radiation TherapyActive, not recruitingNCT03768492Phase 2
- Testosterone Implants and the Incidence of Breast CancerCompletedNCT03768258
- Mini-AFTERc Intervention for Fear of Cancer RecurrenceStatus unknownNCT03763825Not applicable
- Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast CancerApproved for marketingNCT03763604
- The Effect of Acupuncture for Insomnia in Breast Cancer Patients Undergoing ChemotherapyCompletedNCT03762694Not applicable
- Trends of Mastectomy and Breast-Conserving Surgery in Female Breast Cancer PatientsCompletedNCT03762642
- New Therapeutic Approach in Upper Limb Lymphedema Secondary to Breast Cancer: Activity-oriented Proprioceptive Antiedema Therapy (TAPA)CompletedNCT03762044Not applicable
- Health Status of Women With Breast CancerStatus unknownNCT03761940
- Impact of Home-based Aerobic and Strength Exercises During Chemotherapy for Early Breast Cancer on Biomarkers of AgingCompletedNCT03761706Not applicable
- Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Adherence and Clinical OutcomeCompletedNCT03761420
- Synergic Effects of Physical Activity and Probiotic on Gut Immune System and Quality of Life of Breast Cancer Survivors.WithdrawnNCT03760653Not applicable
- Prevention of Cardiac Dysfunction During Breast Cancer TherapyCompletedNCT03760588Phase 2
- Nutritional Status and Pharmacological Treatment: Impact on the Toxicity and Quality of Life of Patients With Colorectal and Breast CancerStatus unknownNCT03759548
- The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast CancerStatus unknownNCT03756090Not applicable
- Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast CancerStatus unknownNCT03756064Not applicable
- Phase III Trial Evaluating Radium Bromatum Homeopathic Treatment Efficacy on Radiodermatitis Prevention and Treatment for Breast Cancer WomenCompletedNCT03753776Phase 3
- A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)CompletedNCT03752398Phase 1
- Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer SurvivorsTerminatedNCT03751449Not applicable
- Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast CancerStatus unknownNCT03749850Phase 1
- Prospective Study of the Prosigna Assay on Neoadjuvant Clinical Decision-making in Women With HR+/Her2- Breast CancerCompletedNCT03749421
- Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2)Active, not recruitingNCT03748550Not applicable
- Hybrid PET/MR Imaging of Acute Cardiac Inflammation After Left-Sided Breast Cancer RadiotherapyStatus unknownNCT03748030
- A Phase 1 Study of [225Ac]-FPI-1434 InjectionTerminatedNCT03746431Phase 1
- Capsule Biopsy in Acellular Dermal Matrix-based Prosthetic Breast Reconstruction: a Prospective Pilot StudyCompletedNCT03744273Not applicable
- Application of Intra-operative Prophylactic Antibiotics/Antiseptics in Chinese Breast Reconstruction PatientsStatus unknownNCT03742908Not applicable
- Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).TerminatedNCT03742349Phase 1
- Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast CancerActive, not recruitingNCT03742245Phase 1
- Effects of Music or Hypnotherapy on Cancer Patients During ChemotherapyTerminatedNCT03740984Not applicable
- Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast CancerWithdrawnNCT03740945Phase 3
- Vaginal Laser Therapy in Breast Cancer SurvivorsStatus unknownNCT03738605Not applicable
- Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast CancerActive, not recruitingNCT03737695
- Standard Silicone-based vs. B-Lite® Light Weight Breast Implant After Total Mastectomy and Radiotherapy for Breast CancerCompletedNCT03737500Not applicable
- Comparison of Conventional With Sonography Assisted Breast Surgery After Neoadjuvant ChemotherapyCompletedNCT03737266Not applicable
- Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients.CompletedNCT03735966Phase 2
- Effectiveness of Liquid Crystal Contact Thermography in Detecting Pathological Changes in Female BreastsStatus unknownNCT03735550
- Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast CancerStatus unknownNCT03735082Phase 2
- Prospective Trial of Digital Breast Tomosynthesis (DBT) in Breast Cancer Screening.Status unknownNCT03733106Not applicable
- Phase 2 Study of Pembrolizumab+Carboplatin in Breast Related Cancer Antigens-related Metastatic Breast Cancer (PEMBRACA)CompletedNCT03732391Phase 2
- CTC in Predicting Neoadjuvant Chemotherapy Among LABC Patients: a Single-center, Prospective, Exploratory Clinical TrialCompletedNCT03732339Not applicable
- Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast CancerActive, not recruitingNCT03731845Not applicable
- The LightPath® and 68Ga-RM2 in Breast Cancer StudyStatus unknownNCT03731026Phase 3
- Water-based Versus Land-based Exercise for Breast Cancer SurvivorsCompletedNCT03730818Not applicable
- American Ginseng for the Prevention of Moderate-severe Fatigue in Breast Cancer PatientsStatus unknownNCT03730298Not applicable
- Targeted Next Generation Sequencing for the Efficacy of Trastuzumab Neoadjuvant Chemotherapy in Breast CancerStatus unknownNCT03728829
- FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PETCompletedNCT03726931Not applicable
- ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid TumorsCompletedNCT03725436Phase 1
- Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)Active, not recruitingNCT03725059Phase 3
- Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing ChemotherapyTerminatedNCT03723863Not applicable
- Imaging With [11C]Martinostat in Breast CancerWithdrawnNCT03721211Phase 1
- TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast CancerStatus unknownNCT03720431Phase 1
- Sentinel Lymph Node Biopsy After Neoadjuvant Treatment in Breast Cancer PatentsCompletedNCT03719833
- Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast CancerCompletedNCT03719495
- A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic MalignanciesCompletedNCT03719326Phase 1
- Low Energy Dissection Vs. Electrocautery in Lumpectomy Shaved Surgical MarginsStatus unknownNCT03718442
- Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast CancerCompletedNCT03716583Phase 2
- Clinical Significance of Supraclavicular Lymph Node Dissection for Breast CancerCompletedNCT03716245Not applicable
- DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BCActive, not recruitingNCT03716180Phase 1
- Nipple Aspirate Fluid in Detecting Breast CancerCompletedNCT03715959Not applicable
- To Accurately Assess Lymph Node Response to NACT by Wire Localization of Clip-marked Lymph NodesStatus unknownNCT03715686Not applicable
- Blood Brain Barrier Disruption (BBBD) Using MRgFUS in the Treatment of Her2-positive Breast Cancer Brain MetastasesCompletedNCT03714243Not applicable
- Mid-point Transverse Process to Pleura Block for Breast Cancer Surgery: A Randomized Controlled TrialStatus unknownNCT03713255Not applicable
- CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCERActive, not recruitingNCT03712956Phase 2
- Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer SurvivorsCompletedNCT03712813Not applicable
- Descriptive Observational Study of the Evolution of the Lifestyle Alteration in Patients With Breast CancerCompletedNCT03712176
- Post-Operative Outcomes of Low Thermal Dissection vs. Traditional ElectrosurgeryCompletedNCT03711916Not applicable
- Comparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study)Status unknownNCT03711877Phase 3
- Impact of Tumor Bed Localisation on Dosimetry Boost Irradiation in Patients Undergoing Breast Conserving SurgeryStatus unknownNCT03710018
- Leflunomide in Previously Treated Metastatic Triple Negative CancersCompletedNCT03709446Phase 1/2
- Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRICompletedNCT03709186
- Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant ChemotherapyCompletedNCT03709134
- Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast CancerTerminatedNCT03709082Phase 1/2
- 500mg Fulvestrant in HR+ MBCCompletedNCT03708432
- Weight Bearing Exercise in Preventing Frailty in Stage I-IIIA Breast Cancer SurvivorsCompletedNCT03708055Not applicable
- A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase InhibitorsActive, not recruitingNCT03707340Phase 2
- Managed Access Program to Provide Alpelisib for Patients With HR+ Advanced or Metastatic Breast CancerNo longer availableNCT03706573
- Breast Ultrasound Image Reviewed With Assistance of Deep Learning AlgorithmsStatus unknownNCT03706534Not applicable
- A Study Comparing Two Standard of Care Adjuvant Chemotherapy Regimens for Lower Risk HER-2 Positive Breast CancerCompletedNCT03705429Phase 3
- Relationship Between Genetic Polymorphism and Postoperative Nausea and Vomiting in Chinese Han PopulationCompletedNCT03705026
- Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast CancerCompletedNCT03703557Not applicable
- Relationship Between Gut Microbiome and Adjuvant Chemotherapy in Patients With Early Breast CancerTerminatedNCT03702868
- Responsiveness to Acute Changes in Exercise and Relaxation (RACER) TrialCompletedNCT03702712Not applicable
- A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast CancerActive, not recruitingNCT03701334Phase 3
- Delphinus SoftVue™ ROC Reader StudyCompletedNCT03698942
- Phase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast CancerStatus unknownNCT03698383Phase 2
- CDK and Body Composition StudyCompletedNCT03697577
- Auricular Point Acupressure to Self-Manage Chronic Pain or Aromatase Inhibitor Musculoskeletal Symptoms in Breast Cancer Survivors: Effectiveness and Scientific UnderpinningsCompletedNCT03697200Not applicable
- Improving Brain Function After Breast Cancer StudyCompletedNCT03696056Not applicable
- HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal MetastasesActive, not recruitingNCT03696030Phase 1
- Outcome of Neo-adjuvant Chemotherapy Followed by Breast Conservative Surgery in Breast Cancer in Upper EgyptStatus unknownNCT03696004Phase 2/3
- 500mg Fulvestrant Versus Everolimus Plus Exemestane in MBC Patients Refractory to Previous AICompletedNCT03695341
- Safety and Efficacy of SCT200 in Patients With Relapsed or Metastatic Triple Receptor Negative Breast CancerStatus unknownNCT03692689Phase 2
- Biomarker Study of the Antitumoral Activity of Denosumab in the Pre- Operative Setting of Early Breast CancerStatus unknownNCT03691311Early Phase 1
- A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast CancerActive, not recruitingNCT03691051Phase 2
- Iodine Supplementation on Breast CancerStatus unknownNCT03688958Phase 2
- Clinical Implementation of a Polygenic Risk Score (PRS) for Breast CancerCompletedNCT03688204
- Potential of Circulating Tumor DNA to Assess the Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer PatientsStatus unknownNCT03688035